#1 Clinical Trials Search in Europe

Indacaterol Acetate

This article examines the use of Indacaterol Acetate, a long-acting beta-2 agonist, in clinical trials for asthma treatment. We’ll look at its efficacy, safety, and potential benefits compared to other asthma medications across multiple studies involving both adult and pediatric patients.

Table of Contents

What is Indacaterol Acetate?

Indacaterol Acetate is a medication used to treat respiratory conditions, primarily asthma. It belongs to a class of drugs called long-acting beta-2 agonists (LABAs). Indacaterol Acetate is also known by its research name QAB149[1]. This medication is designed to help patients breathe more easily by relaxing and opening the airways in the lungs.

How Does Indacaterol Acetate Work?

Indacaterol Acetate works by stimulating specific receptors in the lungs called beta-2 receptors. When these receptors are activated, they cause the muscles around the airways to relax, which helps to open up the airways. This makes it easier for air to flow in and out of the lungs, reducing symptoms such as wheezing, coughing, and shortness of breath[1].

Conditions Treated

The primary condition treated by Indacaterol Acetate is:

  • Asthma: A chronic respiratory condition characterized by inflammation and narrowing of the airways, leading to breathing difficulties[1][2].

Dosage and Administration

Indacaterol Acetate is typically administered through inhalation using a special device. In clinical trials, different doses have been studied:

  • 75 μg once daily[1]
  • 150 μg once daily[1][2]
  • 400 μg once daily (in some studies)[3]

The medication is usually delivered using a dry-powder inhaler called the Concept1 device[1][2]. It’s important to note that the appropriate dose may vary depending on the individual patient and should be determined by a healthcare professional.

Efficacy and Benefits

Clinical trials have shown several potential benefits of Indacaterol Acetate:

  • Improved lung function: Measured by an increase in FEV1 (Forced Expiratory Volume in 1 second), which is the amount of air a person can forcefully exhale in one second[1][2].
  • Better asthma control: Assessed using questionnaires like the Asthma Control Questionnaire (ACQ)[4].
  • Reduced need for rescue medication: Patients may require less use of short-acting inhalers for quick relief of symptoms[4].
  • Improved quality of life: Measured using tools like the Asthma Quality of Life Questionnaire (AQLQ)[4].

Side Effects and Safety

As with all medications, Indacaterol Acetate may cause side effects. Common side effects observed in clinical trials include:

  • Cough
  • Headache
  • Upper respiratory tract infections

It’s important to note that the safety profile of Indacaterol Acetate is still being studied in ongoing clinical trials. Patients should always discuss potential risks and benefits with their healthcare provider[4].

Ongoing Research

Indacaterol Acetate is still being studied in various clinical trials to further understand its efficacy and safety profile. Some areas of ongoing research include:

  • Use in children with asthma aged 6-11 years[1]
  • Comparison with other asthma medications[4]
  • Long-term safety and efficacy studies[4]
  • Combination therapy with other asthma medications, such as mometasone furoate[4]

These ongoing studies aim to provide more comprehensive information about the use of Indacaterol Acetate in different patient populations and its long-term effects.

Aspect Details
Drug Indacaterol Acetate
Type Long-acting beta-2 agonist (LABA)
Administration Inhaled, typically via dry-powder inhaler
Doses studied 75 μg, 150 μg, 400 μg
Patient groups Adults and children (6 years and older) with asthma
Primary outcomes Improvement in lung function (FEV1)
Secondary outcomes Asthma control, quality of life, rescue medication use
Comparators Placebo, Mometasone Furoate, other asthma medications
Safety assessment Adverse events, serious adverse events

FAQ

  • What is Indacaterol Acetate? Indacaterol Acetate is a long-acting beta-2 agonist (LABA) used in the treatment of asthma. It works by relaxing the muscles in the airways to improve breathing.
  • How is Indacaterol Acetate administered? In the clinical trials, Indacaterol Acetate was administered via inhalation using devices such as the Concept1 single-dose dry-powder inhaler.
  • What doses of Indacaterol Acetate were studied? Various doses were studied, including 75 μg, 150 μg, and 400 μg, depending on the specific trial and patient group.
  • Were there any side effects observed with Indacaterol Acetate? The trials included safety assessments, but specific side effects were not detailed in the provided information. As with all medications, patients should discuss potential side effects with their healthcare provider.
  • How does Indacaterol Acetate compare to other asthma treatments? Some trials compared Indacaterol Acetate to other treatments like Mometasone Furoate or placebo. The studies aimed to assess its efficacy in improving lung function and asthma control compared to these alternatives.

Ongoing Clinical Trials on Indacaterol Acetate

  • Study on the Effectiveness and Safety of Indacaterol Acetate/Mometasone Furoate vs. Budesonide for Children Aged 6-11 with Asthma

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Bulgaria Czechia Greece Hungary Italy +3

  • Efficacy and safety of indacaterol acetate (combined with glycopyrronium bromide and mometasone furoate) versus salmeterol/fluticasone in adolescents with asthma

    Not yet recruiting

    3 1 1
    Investigated drugs:
    France Germany Hungary Poland Romania Slovakia +1

Glossary

  • FEV1: Forced Expiratory Volume in 1 second, which is the amount of air a person can forcefully exhale from their lungs in the first second of a forced exhalation. It's a key measure of lung function in asthma patients.
  • Trough FEV1: The FEV1 measured at the end of a dosing interval, typically just before the next dose is due. It represents the lowest level of lung function improvement from the medication.
  • Peak Expiratory Flow (PEF): The maximum speed of exhalation. It's often measured using a small, hand-held device called a peak flow meter.
  • Asthma Control Questionnaire (ACQ): A standardized set of questions used to assess how well a patient's asthma symptoms are controlled.
  • Pharmacokinetics: The study of how a drug moves through the body, including its absorption, distribution, metabolism, and excretion.
  • Bronchodilator: A substance that dilates the bronchi and bronchioles, decreasing resistance in the respiratory airway and increasing airflow to the lungs.
  • Spirometry: A common test used to assess how well your lungs work by measuring how much air you inhale and exhale, and how quickly you exhale.
  • Asthma exacerbation: A worsening of asthma symptoms that may require additional treatment or hospitalization.

References

  1. https://clinicaltrials.gov/study/NCT02892019
  2. https://clinicaltrials.gov/study/NCT03257995
  3. https://clinicaltrials.gov/study/NCT00927901
  4. https://clinicaltrials.gov/study/NCT02554786